Skip to main navigation Skip to search Skip to main content

An Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors

  • Yong Chen Lu
  • , Zhili Zheng
  • , Paul F. Robbins
  • , Eric Tran
  • , Todd D. Prickett
  • , Jared J. Gartner
  • , Yong F. Li
  • , Satyajit Ray
  • , Zulmarie Franco
  • , Valery Bliskovsky
  • , Peter C. Fitzgerald
  • , Steven A. Rosenberg

    Research output: Contribution to journal › Article › peer-review

    95 Scopus citations

    Abstract

    The adoptive transfer of neoantigen-reactive tumor-infiltrating lymphocytes (TILs) can result in tumor regression in patients with metastatic cancer. To improve the efficacy of adoptive T cell therapy targeting these tumor-specific mutations, we have proposed a new therapeutic strategy, which involves the genetic modification of autologous T cells with neoantigen-specific T cell receptors (TCRs) and the transfer of these modified T cells back to cancer patients. However, the current techniques to isolate neoantigen-specific TCRs are labor intensive, time consuming, and technically challenging, not suitable for clinical applications. To facilitate this process, a new approach was developed, which included the co-culture of TILs with tandem minigene (TMG)-transfected or peptide-pulsed autologous antigen-presenting cells (APCs) and the single-cell RNA sequencing (RNA-seq) analysis of T cells to identify paired TCR sequences associated with cells expressing high levels of interferon-γ (IFN-γ) and interleukin-2 (IL-2). Following this new approach, multiple TCRs were identified, synthesized, cloned into a retroviral vector, and then transduced into donor T cells. These transduced T cells were shown to specifically recognize the neoantigens presented by autologous APCs. In conclusion, this approach provides an efficient procedure to isolate neoantigen-specific TCRs for clinical applications, as well as for basic and translational research. The identification of antigen-specific T cell receptors (TCRs) is a complicated process, which is technically challenging and not suitable for clinical applications. To simplify this process, Lu and colleagues developed an efficient single-cell approach, which can significantly reduce the labor and time for the TCR isolation.

    Original languageEnglish
    Pages (from-to)379-389
    Number of pages11
    JournalMolecular Therapy
    Volume26
    Issue number2
    DOIs
    StatePublished - Feb 7 2018

    Keywords

    • cancer immunotherapy
    • gene therapy
    • single cell

    Fingerprint

    Dive into the research topics of 'An Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors'. Together they form a unique fingerprint.

    Cite this